Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 months.
Ertugrul AD, Neto AS, Fulcher BJ, Charles-Nelson A, Bailey M, Burrell AJC, Anderson S, Bernard S, Board JV, Brodie D, Buhr H, Cooper DJ, Dicker C, Fan E, Fraser JF, Gattas DJ, Hopper IK, Huckson S, Linke NJ, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Stub D, Udy AA, Reddi BAJ, Trapani TV, Jones A, Higgins AM, Hodgson CL; EXCEL Study Investigators and the International ECMO Network (ECMONet). Ertugrul AD, et al. Crit Care Resusc. 2024 Nov 22;26(4):262-270. doi: 10.1016/j.ccrj.2024.08.006. eCollection 2024 Dec. Crit Care Resusc. 2024. PMID: 39781494 Free PMC article.
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Nat Med. 2024 Dec;30(12):3780. doi: 10.1038/s41591-024-03349-0. Nat Med. 2024. PMID: 39653780 Free PMC article. No abstract available.
Profiling immune cell tissue niches in the spatial -omics era.
Lee CYC, McCaffrey J, McGovern D, Clatworthy MR. Lee CYC, et al. Among authors: mccaffrey j. J Allergy Clin Immunol. 2024 Nov 8:S0091-6749(24)01178-3. doi: 10.1016/j.jaci.2024.11.001. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39522655 Free article. Review.
Correction: Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation.
Burrell A, Bailey MJ, Bellomo R, Buscher H, Eastwood G, Forrest P, Fraser JF, Fulcher B, Gattas D, Higgins AM, Hodgson CL, Litton E, Martin EL, Nair P, Ng SJ, Orford N, Ottosen K, Paul E, Pellegrino V, Reid L, Shekar K, Totaro RJ, Trapani T, Udy A, Ziegenfuss M, Pilcher D; BLENDER Trial Investigators, EXCEL Registry, ECMONet and the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group and Centre for Outcomes and Resource Evaluation. Burrell A, et al. Intensive Care Med. 2024 Dec;50(12):2241-2242. doi: 10.1007/s00134-024-07677-0. Intensive Care Med. 2024. PMID: 39412548 Free PMC article. No abstract available.
Neutrophil extracellular traps protect the kidney from ascending infection and are required for a positive leukocyte dipstick test.
Stewart AP, Loudon KW, Routledge M, Lee CYC, Trotter P, Richoz N, Gillman E, Antrobus R, Mccaffrey J, Posner D, Conway Morris A, Karet Frankl FE, Clatworthy MR. Stewart AP, et al. Among authors: mccaffrey j. Sci Transl Med. 2024 Sep 25;16(766):eadh5090. doi: 10.1126/scitranslmed.adh5090. Epub 2024 Sep 25. Sci Transl Med. 2024. PMID: 39321268
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, Dummer R, Butler MO, Hill AG, Postow MA, Gaudy-Marqueste C, Medina T, Lao CD, Walker J, Márquez-Rodas I, Haanen JBAG, Guidoboni M, Maio M, Schöffski P, Carlino MS, Sandhu S, Lebbé C, Ascierto PA, Long GV, Ritchings C, Nassar A, Askelson M, Benito MP, Wang W, Hodi FS, Larkin J; CheckMate 067 Investigators. Wolchok JD, et al. N Engl J Med. 2025 Jan 2;392(1):11-22. doi: 10.1056/NEJMoa2407417. Epub 2024 Sep 15. N Engl J Med. 2025. PMID: 39282897 Clinical Trial.
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.
Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, Kurzeder C, Higgins MJ, Connolly RM, Baron-Hay S, Gión M, Guarneri V, Bianchini G, Wildiers H, Escrivá-de-Romaní S, Prahladan M, Bridge H, Kuptsova-Clarkson N, Scotto N, Verma S, Lin NU; DESTINY-Breast12 study group. Harbeck N, et al. Nat Med. 2024 Dec;30(12):3717-3727. doi: 10.1038/s41591-024-03261-7. Epub 2024 Sep 13. Nat Med. 2024. PMID: 39271844 Free PMC article. Clinical Trial.
Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation.
Burrell A, Bailey MJ, Bellomo R, Buscher H, Eastwood G, Forrest P, Fraser JF, Fulcher B, Gattas D, Higgins AM, Hodgson CL, Litton E, Martin EL, Nair P, Ng SJ, Orford N, Ottosen K, Paul E, Pellegrino V, Reid L, Shekar K, Totaro RJ, Trapani T, Udy A, Ziegenfuss M, Pilcher D; BLENDER Trial Investigators, EXCEL Registry, ECMONet and the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group and Centre for Outcomes and Resource Evaluation. Burrell A, et al. Intensive Care Med. 2024 Sep;50(9):1470-1483. doi: 10.1007/s00134-024-07564-8. Epub 2024 Aug 20. Intensive Care Med. 2024. PMID: 39162827 Free PMC article. Clinical Trial.
388 results